Bio-Rad Laboratories, Inc.Class A (BIO) News

Latest headlines that mention BIO, newest first · each headline opens the original publisher

BIO quote

Last price: $393.23
Day change: +3.06%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

BIO headlines

last 30 days

Motley Fool 4d ago

Bio-Rad (BIO) Q3 2026 Earnings Call Transcript

Digital PCR demand and cost cuts shaped a quarter despite academic softness.

Earnings T3BIO

Seeking Alpha 4d ago

Bio-Rad reaffirms 2026 currency-neutral revenue growth at (-3%) to 0.5% while targeting non-GAAP operating margin in upper half of 10% to 12% range

Earnings T2BIO

Seeking Alpha News 4d ago

Bio-Rad Laboratories, Inc. (BIO) Q3 2026 Earnings Call Transcript

Earnings T2BIO

Seeking Alpha News 4d ago

Bio-Rad Laboratories, Inc. 2026 Q3 - Results - Earnings Call Presentation

Earnings T2BIO

Seeking Alpha 4d ago

Bio-Rad Laboratories, Inc. GAAP EPS of $2.65, revenue of $656.4M beats by $6.45M

Earnings T2BIO

Investing.com 5d ago

Bio-Rad earnings up next: Can diagnostics firm sustain momentum?

Earnings T3BIO

BIO news alerts

Get an alert by email or push when a new headline mentions BIO.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.